132 related articles for article (PubMed ID: 2686538)
1. An experimental model for oncogene activation during tumor progression in vivo.
Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Cosma GN; Sawey MJ
Anticancer Res; 1989; 9(5):1439-46. PubMed ID: 2686538
[TBL] [Abstract][Full Text] [Related]
2. The c-myc oncogene in tumor progression.
Garte SJ
Crit Rev Oncog; 1993; 4(4):435-49. PubMed ID: 8353142
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors.
Garte SJ; Burns FJ; Ashkenazi-Kimmel T; Felber M; Sawey MJ
Cancer Res; 1990 May; 50(10):3073-7. PubMed ID: 2185880
[TBL] [Abstract][Full Text] [Related]
4. Oncogenes and tumor progression.
Muschel RJ; McKenna WG
Anticancer Res; 1989; 9(5):1395-406. PubMed ID: 2686535
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
Bisgaard HC; Ton PT; Nagy P; Thorgeirsson SS
J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
[TBL] [Abstract][Full Text] [Related]
6. Role of oncogenes and tumor suppressor genes in a multistep model of carcinogenesis.
Barrett JC; Oshimura M; Koi M
Symp Fundam Cancer Res; 1986; 39():45-56. PubMed ID: 3321309
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
8. Quantitative variations in gene expression: possible role in cellular diversification and tumor progression.
Nicolson GL
J Cell Biochem; 1991 Aug; 46(4):277-83. PubMed ID: 1757473
[TBL] [Abstract][Full Text] [Related]
9. Oncogene Expression and Cellular Radiation Resistance: A Modulatory Role for c-myc.
Chiang CS; Sawyers CL; Mcbride WH
Mol Diagn; 1998 Mar; 3(1):21-27. PubMed ID: 10096954
[TBL] [Abstract][Full Text] [Related]
10. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
[TBL] [Abstract][Full Text] [Related]
11. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
Storer RD; Allen HL; Kraynak AR; Bradley MO
Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
[TBL] [Abstract][Full Text] [Related]
12. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
[TBL] [Abstract][Full Text] [Related]
14. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
15. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
Felsher DW
Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
[TBL] [Abstract][Full Text] [Related]
16. PA-1, a human cell model for multistage carcinogenesis: oncogenes and other factors.
Tainsky MA; Krizman DB; Chiao PJ; Yim SO; Giovanella BC
Anticancer Res; 1988; 8(5A):899-913. PubMed ID: 3052262
[TBL] [Abstract][Full Text] [Related]
17. Gene expression, cellular diversification and tumor progression to the metastatic phenotype.
Nicolson GL
Bioessays; 1991 Jul; 13(7):337-42. PubMed ID: 1759975
[TBL] [Abstract][Full Text] [Related]
18. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
19. Metastasis-Associated genes and metastatic tumor progression.
Nicolson GL; Moustafa AS
In Vivo; 1998; 12(6):579-88. PubMed ID: 9891220
[TBL] [Abstract][Full Text] [Related]
20. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
